Results 201 to 210 of about 87,366 (344)

One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis. [PDF]

J Ren Nutr, 2019
Kendrick J, Parameswaran V, Ficociello LH, Ofsthun NJ, Davis S, Mullon C, Kossmann RJ, Kalantar-Zadeh K.   +7 more
europepmc   +1 more source

How to assess the efficacy of phosphate binders

, 2017
Francisco Caravaca, Fernando Caravaca‐Fontán, Lilia Azevedo, Enrique Luna   +3 more
openalex   +1 more source

Phosphate binder pill burden, patient‐reported non‐adherence, and mineral bone disorder markers: Findings from the DOPPS [PDF]

, 2015
Rachel B. Fissell, Angelo Karaboyas, Brian Bieber, Ananda Sen, Yun Li, Antonio A. Lopes, Takashi Akiba, Jürgen Bommer, Jean Éthier, Michel Jadoul, Ronald L. Pisoni, Bruce Robinson, Francesca Tentori   +12 more
openalex   +1 more source

YIPFα1A expression is regulated by multilayered molecular mechanisms

FEBS Open Bio, EarlyView.
YIPFα1A, a five‐pass Golgi protein, is regulated at multiple layers. (1) Rare‐codon enrichment drives translation‐coupled mRNA decay. (2) A proximal 3′‐UTR element stabilizes mRNA. (3) A distal 3′‐UTR element included by alternate poly(A) site usage represses translation, which can be overridden by the proximal 3′‐UTR element.
Tokio Takaji, Yurika Nakanishi, Nobuhiro Nakamura   +2 more
wiley   +1 more source

Identifying transcription factors controlling the basal expression of human MRP4 highlights a substantial role for Sp1

FEBS Open Bio, EarlyView.
The MRP4 transporter exports several drugs and signaling molecules. Here, we identified key promoter elements regulating basal MRP4 expression. Using reporter assays, we defined a conserved region with essential Sp1 and contributory Ets sites, which controlled basal MRP4 expression.
Debora Singer, Angelique Kragl, Katrin Ziems, Juliane Glaubitz, Sophie Grammbauer, Susanne Hildebrandt, Mladen V. Tzvetkov, Gabriele Jedlitschky   +7 more
wiley   +1 more source

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling

FEBS Open Bio, EarlyView.
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero, Maria Kopsida, Nathalie Arendt, Hans Lennernäs, Markus Sjöblom, Femke Heindryckx   +5 more
wiley   +1 more source

PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure. [PDF]

PLoS One, 2017
Yaguchi A, Tatemichi S, Takeda H, Kobayashi M.   +3 more
europepmc   +1 more source

Dependence of the samples’ properties of highalumina rammed mass on phosphate binder before and after heat treatment on the amount of combined chromium oxide and zirconium oxide additive

I. V. Khonchyk
openalex   +2 more sources

A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

, 2017
Wendy L. St. Peter, Lori D Wazny, Eric D. Weinhandl, Katie E. Cardone, Joanna Q. Hudson   +4 more
openalex   +1 more source

Early‐life high‐fat diet exposure increases Achilles tendon stiffness and induces transcriptomic alterations

FEBS Open Bio, EarlyView.
Early‐life exposure to a high‐fat diet altered intact Achilles tendons in rat offspring, making them thinner, stiffer, and molecularly distinct even without injury. These findings suggest that developmental high‐fat diet exposure may impair tendon quality and increase susceptibility to mechanical overload or tendon injury later in life.
Heyong Yin, Ziyang Yuan, Wenli Jiang, Ai Guo   +3 more
wiley   +1 more source